Background: Vaccinia based immunizations have caused myo/pericarditis and vaccine study volunteers are monitored by ECG. We report ECG outcome obtained during the screening period for an HIV vaccine trial. Methods: ECG was performed in healthy Tanzanian volunteers. ECG abnormalities and findings interfering with the interpretation of myo/pericarditis were subject to study ineligibility. We determined the prevalence of left ventricular hypertrophy (LVH) defined by the Sokolow-Lyon (SL) or the Cornell index, ST-elevations and early repolarization (ERP) in association with gender, age, BMI and body height by regression analysis adjusted for gender and age. Results: In 257 volunteers (median age 23 years, 63% males) overall positivity for LVH defined by SL or Cornell criteria was seen in 20.6% and 3.5%, ST-elevations ≥0.1 mV or ≥0.2 mV in 77.8% and 38.1%, and ERP in 23.4%. Positive SL criteria were associated with male gender (PR 7.84, p < 0.001) and lower age (PR 0.70, p = 0.002), and associated with increased body height and lower BMI in univariate analysis. Positive Cornell criteria were only associated with lower age (PR 0.44, p = 0.010). ST-elevations ≥0.2 mV were associated with male gender (PR 8.05, p < 0.001) and lower age (PR 0.81, p = 0.003), and ERP with male gender (PR 2.86, p < 0.001). Vaccine study ineligibility due to ECG findings was concluded in 22.1% of the screening population. Conclusions: High prevalence of LVH according to SL in association with ST-elevation and ERP is especially http://dx
Introduction
With changing lifestyles and increasing urbanization, cardiovascular disease is increasingly prevalent in sub-Saharan Africa [1] . Electrocardiogram (ECG) is a non-invasive, widely available tool to assess heart disease. Yet, the reference ranges for a valid interpretation of ECG tracings are derived from Caucasian populations and normal ranges for ECG findings in African populations are not very well defined [2, 3, 4] , though many large scale studies in North American populations have pointed out differences in ECG findings between African Americans and Caucasian Americans.
It has been described that voltages in ECG may be higher in populations of African origin and ST changes are more frequent as compared to Caucasian populations [5, 6, 7] . In this respect, left ventricular hypertrophy (LVH) criteria that rely on left or right precordial voltage such as the Sokolow Lyon (SL) Index have been reported to be of low specificity favouring the Cornell criteria in African populations [8, 9, 10, 11, 12] . Independent of ethnic heritage, ST-elevation characterized by an elevation of the QRS-ST junction (J point) has been described to be present in up to 93% of young males [13, 14] . Early repolarization (ERP) characterized by an ST-elevation of ≥ 0.1 mV in multiple leads, often associated with QRS notching or slurring (J wave), is usually viewed as a benign abnormality in young and asymptomatic individuals, but has been associated with an increased risk for ventricular arrhythmias and sudden cardiac death [15] . Frequencies of ERP in the context of ethnic background are discussed controversially, with some reports indicating an overall prevalence of 1-2% independent of race [16] . More recent reports indicate higher prevalence in populations with African heritage as compared to Caucasians [17, 18, 19] .
Vaccinia virus based vaccines have been associated with myo/ pericarditis [20, 21] and volunteers participating in Modified Vaccinia Ankara (MVA) containing vaccine trials are usually ECG monitored for safety [22] . We recently conducted the TaMoVac01 multicentre phase II, MVA containing HIV vaccine trial in healthy volunteers from Tanzania [23] and encountered challenges during eligibility assessments due to high rates of abnormal ECG findings that could potentially interfere with the diagnosis of suspected vaccine induced myo/pericarditis. In a post hoc analysis we here investigate frequencies and factors associated with variable ECG findings in otherwise clinically healthy young Tanzanian volunteers and the related implications for MVA based vaccine studies.
Methods

Study settings and ethics statements
The study was conducted at the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, and the National Institute for Medical Research (NIMR)-Mbeya Medical Research Center (MMRC) in Mbeya. Ethical approval for TaMoVac01 was obtained from the institutional review boards of the Muhimbili University of Health and Allied Sciences and the Mbeya Medical Research Ethics Committee. The Tanzania National Institute for Medical Research (NIMR), serving as the National Ethics Committee, and the Swedish Ethics Committee also approved the study. The study was conducted according to the principles of International Conference of Harmonization and Good Clinical Practice guidelines (ICH-GCP). All volunteers were provided with an information sheet and informed consent was obtained before any study procedures took place.
Study population and eligibility criteria
Volunteers for the TaMoVac 01 HIV vaccine trial were recruited from the Police, Prison forces, and a youth clinic in Dar es Salaam, as well as from the general population in Mbeya in Tanzania. Study volunteers aged 18 years or older underwent screening including medical history, complete physical examination, blood pressure and pulse rate assessments, laboratory analyses (complete blood count, ALT, direct and indirect bilirubin, random blood glucose and creatinine), urine analysis, serology testing for HIV, syphilis and hepatitis B as well as pregnancy testing in females. A 12-lead ECG was recorded during screening in order to exclude volunteers with evidence of cardiac disease and those with abnormalities that would potentially interfere with later diagnosis of MVA induced myo/pericarditis.
As the aim of this post hoc analysis was to investigate incidental ECG variations in a healthy African vaccine trial screening population, we excluded participants from the analysis who met at least one of the following criteria which could potentially lead to ECG abnormalities: HIV infection, evidence of current of past cardiac or cardio-vascular disease as assessed by medical history and physical examination, known hypertension or confirmed systolic blood pressure > 140/90 mm Hg, known diabetes or confirmed moderate or above hyperglycaemia, severe anaemia (haemoglobin levels < 9.0 g/dL), and moderate or above creatinine or ALT elevations to exclude significant renal or hepatic diseases. Severity grades were based on the DAIDS toxicity table (Division of AIDS, Natl. Institutes of Health, Bethesda, MD) [24] . We included women with a positive pregnancy test into this analysis if pregnancy was deemed to be at an early stage (first trimester).
ECG Data Acquisition and Interpretation
ECGs were acquired on a MAC 1200 electrocardiograph (GE Medical Systems) as supine 12-lead ECGs at 25 mm/s with 1 cm/mV. Two trained study physicians at each site interpreted ECGs on paper. A panel of two national and one international cardiologists reviewed the interpretations to reach a final consensus. As TaMoVac 01 was a safety study, volunteers with pathological ECGs or variations that could potentially interfere with the later interpretation of myo/pericarditis were excluded from enrolment in the vaccine trial. Pathological ECGs and variations leading to exclusion from the vaccine trial were defined as: (i) conduction disturbance such as complete left or right bundle branch block or nonspecific intraventricular conduction disturbance with QRS > 120 ms, AV block of any degree, or QTc prolongation (> 440 ms), (ii) significant repolarization (ST segment or T wave) abnormality, (iii) significant atrial or ventricular arrhythmia; frequent atrial or ventricular ectopy, and (iv) ST-elevation consistent with ischemia or evidence of past or evolving myocardial infarction.
In our post hoc analysis we assessed (i) the Sokolow-Lyon Index with S in V1 plus R in V5 or V6 required to surpass 3.5 mV [25] , and (ii) the Cornell Index with S in V3 plus R in aVL required to surpass 2.0 mV in women and 2.8 mV in men [26, 27] to meet criteria for LVH. STElevation was recorded if there was an elevation of the QRS-ST junction (J point) of ≥ 0.1 mV or ≥ 0.2 mV in at least one lead [14, 28] . ERP was defined as an elevation of the QRS-ST junction by at least 0.1 mV in at least two of the following leads: I, II, III, aVF, aVL, V4, V5 or V6 [29] .
Data collection and statistical analysis
ECG, clinical and laboratory data were recorded in study specific case report forms, double-entered into an SQL database, compared and corrected for data entry errors and then extracted for data analysis. The following outcomes were considered during statistical analysis: STelevations ≥ 0.1 mV and ≥0.2 mV, LVH as defined by Sokolow-Lyon and Cornell criteria and ERP. Comparisons of binary and continuous variables between groups were performed using the Wilcoxon rank-sum test. Repeated measures within the same individuals were performed using McNemar's exact test. Poisson regression with robust variance estimates was used to analyse associations of gender, age, body mass index (BMI), and body height (as an indicator for cardiac size) with the above outcome variables in univariate models, and in multivariate models adjusted for gender and age. For all statistical tests an alpha level of < 0.05 was used to define significance. All statistical analyses were performed using Stata statistics software (version 14, StataCorp, College Station, TX, USA), graphs were drawn in MS Excel.
Results
For the TaMoVac01 trial, 508 volunteers underwent screening procedures of whom 263 volunteers, who were not otherwise excluded, received ECG assessments. During the 70 weeks of active follow-up, no cardiac events were noted in the population enrolled in the vaccine study. Of those 263 participants, six were excluded from this analysis due to conditions that might lead to abnormal ECG readings. These conditions were: prior heart disease in two, hypertension in two, HIV infection in one, and significant alcohol abuse in one participant, respectively. Three females with positive pregnancy tests were kept in the analysis as pregnancies were at early stages. Baseline characteristics for the remaining 257 participants included in the analysis are shown in Table 1 . In brief, 63% of participants were males, the median age was 23 years, and the median BMI 21.7 kg/m 2 . Males were slightly but significantly older, taller, had a lower median BMI, had higher median systolic blood pressure, and had lower median heart rate (within normal ranges) as compared to females, respectively.
Overall positivity for LVH either defined by SL or by Cornell criteria was seen in 53 (20.6%) and 9 (3.5%) participants, respectively. STelevation with a threshold of ≥0.1 mV and ≥ 0.2 mV was seen in 200 (77.8%) and 98 (38.1%) participants, respectively, and ERP was detected in 60 (23.4%) participants. The prevalences of above outcomes stratified by gender are shown in Fig. 1 . Significantly higher prevalences of LVH according to SL criteria, ST-elevations, and ERP were detected in males. LVH according to Cornell criteria did not show a significant gender difference, however, a trend towards a higher proportion was seen in females. As indicated above, the SL criteria for LVH were more frequently positive than the Cornell criteria. This was mainly due to the large difference between the prevalence of these two criteria in males (30.3% versus 1.9%, p < 0.001), whereas differences seen in females were not significant (4.2% versus 6.3%, p = 0.727).
In multivariate regression analyses adjusted for gender and age, positive SL criteria were significantly associated with male gender and younger age, whereas lower BMI and increased body height were significantly associated with SL only in univariate analysis (Table 2 ). In contrast, LVH according to Cornell criteria was significantly associated with younger age after adjusting for gender and age in multivariate analysis, but not for gender, BMI, or body height in neither uni-nor multivariate regression analysis. There were significantly higher proportions of concurrent ST segment elevations and ERP among participants with LVH as defined by SL criteria that were not observed with Cornell criteria. ST segment elevation and ERP were significantly associated with male gender in both, univariate and multivariate analyses, and with greater body height in univariate analysis. Additionally, ST elevation was associated with lower BMI in univariate analysis. An association with younger age was shown in multivariate analysis for ST elevations ≥ 0.2 mV. Of note, ERP in association with ST-elevation ≥ 0.2 mV was detected in 40 (15.6%) participants. 20 (7.8%) of those participants demonstrated ERP in association with STelevation ≥ 0.2 mV without high QRS amplitudes as indicated by positive SL criteria, which could potentially indicate a higher risk for catastrophic arrhythmias.
An ECG pattern of a participant with positive LVH SL criteria in combination with ST-elevation and evidence of ERP with notching of the J-point is shown in Fig. 2A and without positive LVH criteria but STelevation in Fig. 2B , which has been referred as a typical "male pattern". In Fig. 2C an example of a participant with ERP is shown with ST-elevation in the limb leads and slurring of the QRS-ST junction which is referred to as a J-wave.
ECG findings leading to ineligibility during the screening period of the vaccine trial were detected in 58/263 (22.1%) volunteers with ECG assessments, and 41 (15.6%) volunteers were screened out only due to ECG abnormalities without meeting other ineligibility criteria. Apart from above described ST-elevation, ERP and left ventricular hypertrophy criteria, other findings leading to ineligibility were abnormal Twave inversion (N = 10), Right Bundle Branch Blocks (N = 6) including one suspected case with a Brugada syndrome, Left Bundle Branch Block (N = 1), higher grade AV-Blocks (N = 2) and ectopic atrial rhythms (N = 2).
Discussion
There was an overall high rate of screen outs in our MVA vector containing HIV vaccine trial due to ECG findings in young and otherwise clinically healthy volunteers in Tanzania. The most commonly encountered ECG abnormalities were signs of left ventricular hypertrophy, ST segment elevation and ERP. Across all ECG abnormalities analysed, male gender and younger age were the predominant factors that influenced the occurrence of most probably clinically insignificant ECG variations. Factors related to body shape and fat distribution such as lower BMI or greater body height were associated with most abnormalities in univariate regression analysis.
Sokolow Lyon criteria presumably over-diagnosed left ventricular hypertrophy in males as compared to the Cornell criteria (30% vs 2%). In contrast, both LVH criteria were positive in females in about one out of twenty individuals and no significant difference in the prevalence between both criteria was seen. Similar results including gender differences with predominance in males presenting positive Sokolow Lyon criteria have been described from different studies conducted in Africa supporting the evidence that Cornell criteria in African popula- 
P. Mann et al. Clinical Trials and Regulatory Science in Cardiology 26 (2017) 1-6
tions should preferentially be used and are less likely to suggest LVH [8, 9, 10, 11, 12] . Sokolow Lyon criteria have mainly been developed on white populations and reasons why these criteria are more likely to result into false positive LVH diagnosis in African origin populations have been attributed to socioeconomic and nutritional factors, differences in body shape, fat distributions, and physiological differences in ventricle sizes [30, 31] . Higher QRS amplitudes in older populations of AfricanAmericans as compared to white populations have been described for both men and women despite comparable left ventricular mass as measured by echocardiography, indicating racial differences which were partly explained by smaller lateral chest diameter in individuals of African origin [32] . As reviewed by Fraley et al. [33] , higher BMI or obesity is known to lead to lower QRS voltages effecting especially ECG LVH criteria that rely on left or right precordial voltage such as the Sokolow Lyon Index. This is likely attributed to variable degrees of chest wall and epicardial fat which may result in increased distances of chest leads to the heart surface. Furthermore, difference in absolute cardiac size might explain gender specific differences in QRS amplitudes and body height has been described as a marker which correlates with left ventricular mass [34] impacting the prevalence of positive Sokolow Lyon criteria. High prevalence of positive Sokolow Lyon criteria especially in young and slender males in our analysis are therefore likely a result of lower BMI associated with younger age, racial characteristics of small lateral chest diameter, gender differences in cardiac size and chest wall impedance because of subcutaneous breast tissue, and lean body mass. As age was one of the predominant variables affecting both positive Sokolow Lyon and Cornell criteria, other factors such as age related myocyte atrophy might have already affected ECG readouts in our young population.
A high predominance of ST-elevation and J-point amplitudes ≥ 0.1 mV has been described as a typical male pattern in contrast to a female pattern which is more often represented with a J-point amplitude < 0.1 mV. ST-elevations have been associated with younger age and male gender in other studies, with proportions comparable to the ones found in our cohort [13, 14] . Furthermore, significant differ- [1] [2] [3] [4] [5] [6] ences in ST elevations among ethnic groups have been reported and were lowest in white populations as compared to African Americans who had the greatest ST elevations in leads I and V3 to V6 [35] . In the same study, BMI was inversely associated with ST-elevations which was also seen in our analysis. As we found a high co-variation of high QRS amplitudes as seen by positive SL criteria and ST-elevation, a possible reason for both findings is an increase in transmission of electrical currents from the heart to the electrodes secondary to less fatty tissue and related decreased distance/impedance. A pattern of ST-elevation consistent with positive criteria for ERP was hence predominantly found in young males in our analysis as well.
As recently reviewed by Ali et al. [15] , the prevalence of ERP varies between 3% and 24% in the general population depending on the population studied with the highest prevalence seen in young males of African heritage and athletes [17, 18] . As in our study population, ERP is usually incidentally diagnosed and considered benign with a negligible likelihood for developing catastrophic arrhythmias if asymptomatic, found in younger age groups, and co-prevalent with LVH on ECG [19, 36, 37, 38, 39] . On the other hand, individuals with ERP patterns associated with ST-elevation of ≥ 0.2 mV have been discussed to be of greater risk for fatal arrhythmias [40, 41, 42] . In our analysis this was found in 7.8% in the absence of high QRS amplitudes -possibly indicating a bias in transmission of electrical currents due to decreased chest wall impedance. The potential prognostic implications of these ECG patterns for fatal arrhythmias in a predominantly young and male African population would need to be determined.
A limitation of our analysis is that the study was not primarily designed to analyse ECG abnormalities and no cardiologic investigations other than clinical assessments and ECGs were performed. In this respect, no echocardiography or troponin evaluations were performed to support cardiac health or exclude morphologically abnormal cardiac conditions. As participants were of young age and clinically healthy by history and clinical examination, we feel that underlying cardiologic disease is unlikely in the vast majority of the individuals. No automated system was used to better standardize ECG analyses and all measurements were performed manually. As all ECGs were interpreted by at least two independent physicians and reviewed by a panel of experienced cardiologists, the likelihood of misinterpretations has been kept to a minimum.
In conclusion, high prevalence of LVH as defined by SL criteria, often associated with ST elevation and early repolarization predominantly seen in young, male, and clinically healthy Africans is a common finding that needs to be taken into consideration when screening for disease or eligibility criteria for potentially cardiotoxic investigational products. In the case of our MVA containing vaccine trial, ECG defined ineligibility was noted in at least 22.1% of the screening population who received ECG assessments. Screen outs due to ECG findings (11.3%) were reported for a North American MVA-containing vaccine trial in a predominantly Caucasian population [43] . The definitions for a "normal" ECG are largely based on references from Caucasian populations and do not necessarily translate into ECG findings in an African population. Investigations that evaluate differences in ECGs by ethnicity commonly refer to African-Americans or older African populations and are often associated with cardiovascular disease. Conversely, our data add to the scarcely available reports of ECG findings in young and healthy Africans. Main factors contributing to abnormal ECG patterns are likely caused by morphological chest characteristics and resulting distances of ECG electrodes to the heart in young African males. In African populations, Cornell criteria should be preferred for the interpretation of LVH by ECG as they appear to be less influenced by anthropomorphic variables and gender. The impact of ERP with STelevations ≥ 0.2 mV, especially in the absence of concomitant positive SL criteria as a risk factor for fatal arrhythmias needs to be further determined in young African populations. study. We would also like to acknowledge the European and Developing Countries Clinical Trials Partnership (EDCTP), the German Ministry of Education and Research (BMBF) and the Swedish International Development Cooperation Agency (Sida) as funders of the TaMoVac01 trial.
